Independently HPLC-Verified Purity Same-Day Shipping Free Shipping on Orders $250+ Lot-Specific COA — Published and Open No Reseller Markup — Direct-Source Pricing
Stock the Shelfthrough Oct 11 40% off everythingUp to 50% on 10+ of the same vial

Research Reference

What Are GLP-1 Receptor Agonists? Research Reference

GLP-1 receptor agonists are a class of synthetic peptides studied as activators of the GLP-1 receptor — a receptor central to incretin signaling and metabolic-pathway research. This page references the receptor biology and the coded variants supplied by Solira; brand names of approved pharmaceuticals are deliberately omitted in favor of research-supply terminology.

Overview

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of synthetic peptides studied as activators of the GLP-1 receptor — a receptor on pituitary somatotrope cells, pancreatic islet cells, and several other cell populations central to incretin signaling and metabolic-pathway research. Solira supplies five coded variants in this category, characterized by their receptor-agonism profile (mono-agonist, dual-receptor, triple-receptor, blend) rather than by their pharmaceutical brand names. All are supplied for in-vitro laboratory research only and are not approved for human use.

Receptor Biology

The GLP-1 receptor (GLP-1R) is a class B G-protein-coupled receptor that signals primarily through Gs / cAMP / PKA cascades upon agonist binding. Three related incretin receptors are co-studied in metabolic research literature: GIP receptor (GIPR), which shares structural homology with GLP-1R and is targeted by dual-agonist compounds; glucagon receptor (GCGR), which is targeted by triple-agonist compounds investigating combined incretin and glucagon-axis signaling; and amylin receptor, which is co-modulated by amylin-class peptides studied alongside GLP-1 agonists. Research investigations of these receptors typically use cultured cell preparations (HEK293 or CHO cells stably expressing the receptor of interest), pancreatic islet preparations, and rodent in-vivo models with serum hormone measurement endpoints.

Solira’s Coded Catalog

Solira references compounds in this category by coded designations rather than by drug brand names — a deliberate framing that reflects research-supply use:

  • GLP-1S — synthetic GLP-1 receptor mono-agonist (long-acting analog). Single-receptor research.
  • GLP-2T — synthetic dual GLP-1 / GIP receptor agonist. Combinatorial receptor research.
  • GLP-3R — synthetic GLP-1 / GIP / glucagon triple receptor agonist. Three-receptor research.
  • CGL+1S — pre-formulated blend combining an amylin-class compound with a GLP-1 receptor mono-agonist. Studied in dual-pathway research where amylin and incretin axes are investigated together.
  • Mazdutide — synthetic dual GLP-1 / glucagon receptor agonist. Distinct from GLP-2T’s GIP-axis pairing.
  • Cagrilintide — synthetic amylin-class peptide, available as a single-component research compound separate from the CGL+1S blend.
  • AOD-9604 — not an incretin receptor agonist. A synthetic 16-amino-acid fragment of human growth hormone (residues 177-191), characterized in preclinical research on lipolysis-pathway and adipose-tissue mechanisms. It is catalogued alongside the compounds above because it appears in the same metabolic research literature, but it acts on a different pathway and is not comparable to them by receptor class.

The full category listing is at the Metabolic Research Peptides catalog.

Research Applications

Published research investigations of GLP-1 receptor agonists span several methodological categories: pituitary endocrinology research using cultured pituitary cell preparations with serum hormone measurement; metabolic pathway research using pancreatic islet preparations and isolated organelle systems; receptor-binding kinetics studies using radiolabeled ligand displacement assays; and downstream signaling research using cAMP accumulation assays, calcium flux measurements, and Western blot analysis of PKA substrate phosphorylation. The combinatorial-receptor approach (dual GLP-1/GIP, triple GLP-1/GIP/glucagon) is a research tool for studying receptor cross-talk in cells expressing multiple incretin receptor types simultaneously.

Documentation

Concentration references convert vial content and diluent volume into resulting solution concentration. Third-party lot reports are published for the compounds where an independent report is on file:

Verification methodology for every lot is documented on how Solira tests every lot.

Storage Characteristics

Lyophilized GLP-1 receptor agonists are stable for 24 months or longer at −20°C in sealed vials, protected from light and moisture. The larger peptide molecular weight in this class (most are 30-50 residue range) makes them more sensitive to freeze-thaw cycles in solution form than smaller research peptides. Reconstituted aqueous solutions should be aliquoted before freezing. See the peptide storage guide for detailed reconstitution protocols.

Related Research

Researcher verification

Solira supplies research peptides to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding you affirm the statements above are true. These products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Scroll to Top